# US 2012/0253377 A1 · Modifiable occlusion device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253377 A1
- Document ID: US20120253377A1
- Status: Published application
- Kind: A1
- Application number: 13/076,474
- Filed: 2011-03-31
- Published: 2012-10-04
- Earliest claimed: 2011-03-31
- Assignees: Codman & Shurtleff, Inc.
- Inventors: Robert Slazas; Juan Lorenzo; Peter Forsythe
- Web page: https://patentgrep.com/patent/US20120253377A1

## CPC

- A61B 17/12045: {double occlusion, e.g. during anastomosis}
- A61B 17/12118: {for positioning in conjunction with a stent}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

An occlusive device suitable for endovascular treatment of an aneurysm in a region of a parent vessel in a patient, including a structure having a fixed porosity and having dimensions suitable for insertion into vasculature of the patient to reach the region of the aneurysm in the parent vessel. The device further includes a frangible material supported by the structure which initially provides a substantial barrier to flow through the frangible material and is capable of at least one of localized rupturing and localized eroding, in the presence of a pressure differential arising at an ostium of a perforator vessel communicating with the parent vessel, within an acute time period to minimize ischemia downstream of the perforator vessel.

## Claims

### Claim 1

An occlusive device suitable for endovascular treatment of an aneurysm in a region of a parent vessel in a patient, comprising:
a structure having a fixed porosity and having dimensions suitable for insertion into vasculature of the patient to reach the region of the aneurysm in the parent vessel; and
a frangible material supported by the structure which initially provides a substantial barrier to flow through the frangible material and is capable of at least one of localized rupturing and localized eroding, in the presence of a pressure differential arising at an ostium of a perforator vessel communicating with the parent vessel, within an acute time period to minimize ischemia downstream of the perforator vessel.

### Claim 2 (depends on 1)

The occlusive device of claim 1 wherein the structure includes metallic struts.

### Claim 3 (depends on 1)

The occlusive device of claim 1 wherein the frangible material includes a thin film.

### Claim 4 (depends on 3)

The occlusive device of claim 3 wherein the film is formed of at least one of cellulose, alginate, urethane, polycaprolactone and polyglycolic acid.

### Claim 5 (depends on 1)

The occlusive device of claim 1 wherein at least a substantial amount of the surface area of the frangible material defines openings at least 10 microns in diameter prior to implantation in the patient.

### Claim 6 (depends on 1)

The occlusive device of claim 1 wherein the frangible material has a thickness ranging between 10 microns to 500 microns prior to implantation in the patient.

### Claim 7 (depends on 1)

The occlusive device of claim 1 wherein the frangible material includes fibers which are capable of parting to serve as the localized rupturing in the presence of the pressure differential.

### Claim 8 (depends on 7)

The occlusive device of claim 7 wherein the fibers include electro-spun polyvinylidene fluoride fibers.

### Claim 9 (depends on 1)

The occlusive device of claim 1 wherein the frangible material includes at least one biodegradable composition.

### Claim 10 (depends on 1)

The occlusive device of claim 1 wherein the structure includes a porous foam.

### Claim 11 (depends on 10)

The occlusive device of claim 10 wherein the frangible material includes at least one biodegradable composition interspersed through at least a portion of the porosity of the foam.

### Claim 12 (depends on 10)

The occlusive device of claim 10 wherein the foam includes porous urethane.

### Claim 13 (depends on 12)

The occlusive device of claim 12 wherein the biodegradable material includes polycaprolactone.

### Claim 14 (depends on 1)

The occlusive device of claim 1 wherein the frangible material is capable of responding to a pressure differential equivalent to one to fifty mm Hg.

### Claim 15 (depends on 1)

The occlusive device of claim 1 wherein the acute time period is less than ten minutes.

### Claim 16

A method of treating an aneurysm in a parent vessel in a patient, comprising:
selecting an occlusive device including a structure having a fixed porosity and having dimensions suitable for insertion into vasculature of the patient, and including a frangible material supported by the structure which initially provides a substantial barrier to flow through the frangible material and is capable of at least one of localized rupturing and localized eroding, in the presence of a pressure differential arising at an ostium of a perforator vessel communicating with the parent vessel, within an acute time period to minimize ischemia downstream of the perforator vessel;
inserting the occlusive device into vasculature of the patient to reach the region of the aneurysm in the parent vessel; and
positioning the occlusive device to occlude flow into the aneurysm.

### Claim 17 (depends on 16)

The method of claim 16 wherein the structure includes metallic struts.

### Claim 18 (depends on 16)

The method of claim 16 wherein the frangible material includes a thin film.

### Claim 19 (depends on 16)

The method of claim 16 wherein at least a substantial amount of the surface area of the frangible material defines openings at least 10 microns in diameter prior to implantation in the patient.

### Claim 20 (depends on 16)

The method of claim 16 wherein the frangible material includes fibers which are capable of parting to serve as the localized rupturing in the presence of the pressure differential.

### Claim 21 (depends on 16)

The method of claim 16 wherein the frangible material includes at least one biodegradable composition.

### Claim 22 (depends on 16)

The method of claim 16 wherein the structure includes a porous foam.

### Claim 23 (depends on 22)

The method of claim 22 wherein the frangible material includes at least one biodegradable composition interspersed through at least a portion of the porosity of the foam.

### Claim 24 (depends on 16)

The method of claim 16 wherein the frangible material is capable of responding to a pressure differential equivalent to one to fifty mm Hg.

### Claim 25 (depends on 16)

The method of claim 16 wherein the acute time period is less than ten minutes.

### Claim 26 (depends on 16)

The method of claim 16 wherein the frangible material has a thickness ranging between 10 microns to 500 microns prior to implantation in the patient.

### Claim 27

An occlusive device suitable for endovascular treatment of an aneurysm in a region of a parent vessel in a patient, comprising:
a structure having a fixed porosity and having dimensions suitable for insertion into vasculature of the patient to reach the region of the aneurysm in the parent vessel; and
a thin film supported by the structure which initially provides a substantial barrier to flow through the frangible material and is capable of at least localized rupturing, in the presence of a pressure differential arising at an ostium of a perforator vessel communicating with the parent vessel, within an acute time period to minimize ischemia downstream of the perforator vessel.

### Claim 28

An occlusive device suitable for endovascular treatment of an aneurysm in a region of a parent vessel in a patient, comprising:
a structure having a fixed porosity and having dimensions suitable for insertion into vasculature of the patient to reach the region of the aneurysm in the parent vessel; and
a frangible material including a plurality of fibers supported by the structure which initially provides a substantial barrier to flow through the frangible material and the fibers being capable of at least localized rupturing, in the presence of a pressure differential arising at an ostium of a perforator vessel communicating with the parent vessel, within an acute time period to minimize ischemia downstream of the perforator vessel.

### Claim 29 (depends on 28)

The occlusive device of claim 28 wherein at least a substantial amount of the surface area of the frangible material defines openings at least 10 microns in diameter prior to implantation in the patient.

### Claim 30 (depends on 28)

The occlusive device of claim 28 wherein the frangible material has a thickness ranging between 10 microns to 500 microns prior to implantation in the patient.

### Claim 31

An occlusive device suitable for endovascular treatment of an aneurysm in a region of a parent vessel in a patient, comprising:
a structure having a fixed porosity and having dimensions suitable for insertion into vasculature of the patient to reach the region of the aneurysm in the parent vessel; and
biodegradable material interspersed through at least a portion of the porosity of the structure which initially provides a substantial barrier to flow through the biodegradable material and being capable of at least localized eroding, in the presence of a pressure differential arising at an ostium of a perforator vessel communicating with the parent vessel, within an acute time period to minimize ischemia downstream of the perforator vessel.

### Claim 32 (depends on 31)

The occlusive device of claim 31 wherein at least a substantial amount of the surface area of the biodegradable material defines openings at least 10 microns in diameter prior to implantation in the patient.

### Claim 33 (depends on 31)

The occlusive device of claim 31 wherein the structure includes a substantially non-biodegradable porous foam defining the fixed porosity through which the biodegradable material is dispersed.

### Claim 33 (depends on 33)

The occlusive device of claim 33 wherein the foam has a thickness ranging between 10 microns to 500 microns prior to implantation in the patient.

### Claim 34 (depends on 33)

The occlusive device of claim 33 wherein the fixed porosity of the foam defines pores having an average diameter ranging between 50 microns to 500 microns.
